Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (321-330 of 367) with videos related to

Pageof 37
Sort By:
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Thrombosis Research|February 4, 2023
Platelet function and soluble P-selectin in patients with primary immune thrombocytopeniaDino Mehic, Jennifer Machacek, Theresa Schramm, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 1, 2020
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension studyBeatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, et al.
Oncology Research and Treatment|December 26, 2022
[Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie]Axel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Plos One|January 5, 2017
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)Oliver Königsbrügge, Florian Posch, Marlies Antlanger, et al.
Research and Practice in Thrombosis and Haemostasis|September 27, 2023
Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adultsBarbara A Konkle, Johannes Oldenburg, John Pasi, et al.
Oncology Research and Treatment|February 14, 2023
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and SwitzerlandAxel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective CohortsAndrés Muñoz, Cihan Ay, Ella Grilz, et al.
Thrombosis and Haemostasis|November 13, 2018
Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String FormationKatharina Seif, Lejla Alidzanovic, Barbara Tischler, et al.
Wiener Medizinische Wochenschrift (1946)|February 28, 2009
[The Club of Female Professors of the Medical University Vienna]Veronika Fialka-Moser, Christa Fonatsch, Erika Jensen-Jarolim, et al.
Pageof 37

Showing results (321-330 of 367) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Thrombosis Research|February 4, 2023
Platelet function and soluble P-selectin in patients with primary immune thrombocytopeniaDino Mehic, Jennifer Machacek, Theresa Schramm, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 1, 2020
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension studyBeatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, et al.
Oncology Research and Treatment|December 26, 2022
[Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie]Axel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Plos One|January 5, 2017
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)Oliver Königsbrügge, Florian Posch, Marlies Antlanger, et al.
Research and Practice in Thrombosis and Haemostasis|September 27, 2023
Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adultsBarbara A Konkle, Johannes Oldenburg, John Pasi, et al.
Oncology Research and Treatment|February 14, 2023
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and SwitzerlandAxel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective CohortsAndrés Muñoz, Cihan Ay, Ella Grilz, et al.
Thrombosis and Haemostasis|November 13, 2018
Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String FormationKatharina Seif, Lejla Alidzanovic, Barbara Tischler, et al.
Wiener Medizinische Wochenschrift (1946)|February 28, 2009
[The Club of Female Professors of the Medical University Vienna]Veronika Fialka-Moser, Christa Fonatsch, Erika Jensen-Jarolim, et al.
Pageof 37